Summary

Market Overview
The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market’s growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.
For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen—demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.
Key Market Drivers
Surge in Biopharmaceutical Demand and Biosimilar Production
The growing demand for biopharmaceutical products—particularly monoclonal antibodies, vaccines, and biosimilars—is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.
Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.
Key Market Trends
Integration of Digital Technologies in Bioprocessing
The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control—enhancing efficiency, product quality, and compliance.
Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.
Key Market Players
• ABEC, INC.
• Able Corporation & Biott Corporation
• BBI-Biotech GmbH
• Cellexus Biosystems PLC
• Celltainer Biotech BV
• Danaher Corporation
• Distek Inc.
• Eppendorf AG
• G&G Technologies, Inc.
• Getinge AB
Report Scope:
In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Single-Use Bioreactors Market, By Product:
o Single use bioreactor systems
o Single use media bags
o Single use filtration assemblies
o Other products
• Single-Use Bioreactors Market, By Type:
o Stirred tank SUB
o Wave induced SUB
o Bubble Column SUB
o Other SUB
• Single-Use Bioreactors Market, By Type of Cell:
o Mammalian Cell
o Bacterial Cell
o Yeast Cell
o Other Cells
• Single-Use Bioreactors Market, By Molecule:
o Monoclonal Antibodies
o Vaccines
o Gene Modified Cells
o Stem Cells
o Other molecules
• Single-Use Bioreactors Market, By Application:
o Research and Development
o Bioproduction
• Single-Use Bioreactors Market, By Usage:
o Lab scale production
o Pilot scale production
o Large scale production
• Single-Use Bioreactors Market, By End User:
o Pharmaceutical and Biopharmaceutical companies
o CROSs & CMOS
o Academic and Research Institutes
• Single-Use Bioreactors Market, By Region:
o North America
  § United States
  § Mexico
  § Canada
o Europe
  § France
  § Germany
  § United Kingdom
  § Italy
  § Spain
o Asia-Pacific
  § China
  § India
  § South Korea
  § Japan
  § Australia
o South America
  § Brazil
  § Argentina
  § Colombia
o Middle East and Africa
  § South Africa
  § Saudi Arabia
  § UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.
Available Customizations:
Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Single-Use Bioreactors Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
5.2.5. By Application (Research and Development, Bioproduction)
5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.9. By Company (2024)
5.3. Market Map
5.3.1 By Product
5.3.2 By Type
5.3.3 By Type of Cell
5.3.4 By Molecule
5.3.5 By Application
5.3.6 By Usage
5.3.7 By End User
5.3.5 By Region
6. North America Single-Use Bioreactors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
6.2.5. By Application (Research and Development, Bioproduction)
6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
6.2.8. By Country
6.3. North America: Country Analysis
6.3.1. United States Single-Use Bioreactors Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Type of Cell
6.3.1.2.4. By Molecule
6.3.1.2.5. By Application
6.3.1.2.6. By Usage
6.3.1.2.7. By End User
6.3.2. Canada Single-Use Bioreactors Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Type of Cell
6.3.2.2.4. By Molecule
6.3.2.2.5. By Application
6.3.2.2.6. By Usage
6.3.2.2.7. By End User
6.3.3. Mexico Single-Use Bioreactors Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Type of Cell
6.3.3.2.4. By Molecule
6.3.3.2.5. By Application
6.3.3.2.6. By Usage
6.3.3.2.7. By End User
7. Europe Single-Use Bioreactors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
7.2.5. By Application (Research and Development, Bioproduction)
7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
7.2.8. By Country
7.3. Europe: Country Analysis
7.3.1. France Single-Use Bioreactors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Type of Cell
7.3.1.2.4. By Molecule
7.3.1.2.5. By Application
7.3.1.2.6. By Usage
7.3.1.2.7. By End User
7.3.2. Germany Single-Use Bioreactors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Type of Cell
7.3.2.2.4. By Molecule
7.3.2.2.5. By Application
7.3.2.2.6. By Usage
7.3.2.2.7. By End User
7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Type of Cell
7.3.3.2.4. By Molecule
7.3.3.2.5. By Application
7.3.3.2.6. By Usage
7.3.3.2.7. By End User
7.3.4. Italy Single-Use Bioreactors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Type of Cell
7.3.4.2.4. By Molecule
7.3.4.2.5. By Application
7.3.4.2.6. By Usage
7.3.4.2.7. By End User
7.3.5. Spain Single-Use Bioreactors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Type of Cell
7.3.5.2.4. By Molecule
7.3.5.2.5. By Application
7.3.5.2.6. By Usage
7.3.5.2.7. By End User
8. Asia-Pacific Single-Use Bioreactors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
8.2.5. By Application (Research and Development, Bioproduction)
8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
8.2.8. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Single-Use Bioreactors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Type of Cell
8.3.1.2.4. By Molecule
8.3.1.2.5. By Application
8.3.1.2.6. By Usage
8.3.1.2.7. By End User
8.3.2. India Single-Use Bioreactors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Type of Cell
8.3.2.2.4. By Molecule
8.3.2.2.5. By Application
8.3.2.2.6. By Usage
8.3.2.2.7. By End User
8.3.3. Japan Single-Use Bioreactors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Type of Cell
8.3.3.2.4. By Molecule
8.3.3.2.5. By Application
8.3.3.2.6. By Usage
8.3.3.2.7. By End User
8.3.4. South Korea Single-Use Bioreactors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Type of Cell
8.3.4.2.4. By Molecule
8.3.4.2.5. By Application
8.3.4.2.6. By Usage
8.3.4.2.7. By End User
8.3.5. Australia Single-Use Bioreactors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Type of Cell
8.3.5.2.4. By Molecule
8.3.5.2.5. By Application
8.3.5.2.6. By Usage
8.3.5.2.7. By End User
9. South America Single-Use Bioreactors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
9.2.5. By Application (Research and Development, Bioproduction)
9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
9.2.8. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Single-Use Bioreactors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Type of Cell
9.3.1.2.4. By Molecule
9.3.1.2.5. By Application
9.3.1.2.6. By Usage
9.3.1.2.7. By End User
9.3.2. Argentina Single-Use Bioreactors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Type of Cell
9.3.2.2.4. By Molecule
9.3.2.2.5. By Application
9.3.2.2.6. By Usage
9.3.2.2.7. By End User
9.3.3. Colombia Single-Use Bioreactors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Type of Cell
9.3.3.2.4. By Molecule
9.3.3.2.5. By Application
9.3.3.2.6. By Usage
9.3.3.2.7. By End User
10. Middle East and Africa Single-Use Bioreactors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
10.2.5. By Application (Research and Development, Bioproduction)
10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
10.2.8. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Single-Use Bioreactors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Type of Cell
10.3.1.2.4. By Molecule
10.3.1.2.5. By Application
10.3.1.2.6. By Usage
10.3.1.2.7. By End User
10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Type of Cell
10.3.2.2.4. By Molecule
10.3.2.2.5. By Application
10.3.2.2.6. By Usage
10.3.2.2.7. By End User
10.3.3. UAE Single-Use Bioreactors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Type of Cell
10.3.3.2.4. By Molecule
10.3.3.2.5. By Application
10.3.3.2.6. By Usage
10.3.3.2.7. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing demand for lab automation activities
11.1.2 Growing adoption of lab informatics by biobanks
11.1.3 Growing introduction of technologically advanced software services
11.2. Challenges
11.2.1 Lack of integration standards for laboratory informatics
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Single-Use Bioreactors Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. ABEC, INC.
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Able Corporation & Biott Corporation.
15.3. BBI-Biotech Gmbh.
15.4. Cellexus Biosystems PLC.
15.5. Celltainer Biotech BV.
15.6. Danaher Corporation
15.7. Distek Inc.
15.8. Eppendorf AG.
15.9. G&G Technologies, Inc.
15.10. Getinge AB
16. Strategic Recommendations
17. About Us & Disclaimer